The Covid-19 pandemic is poised to be a defining moment for the U.S. health care industry. Even as organizations across the country continue to grapple with the immediate impact of the outbreak, leaders are also beginning to plan for the future—with the understanding that the pandemic is reshaping and restructuring the industry in ways that are likely to be permanent. While all can agree that the post-Covid landscape is likely to look notably different from the pre-Covid reality, there is considerable debate about the degree and nature of change the industry will experience.
Read on to get Advisory Board’s take on how Covid-19 will reshape demand, purchaser strategies, the competitive landscape, and delivery models.
…M&A and systemness? (coming soon)
…fixed cost restructuring? (coming soon)
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
Never miss out on the latest innovative health care content tailored to you.